Abstract:BackgroundAccumulation of bone marrow adipose tissue (BMAT) is always seen in osteoporosis induced by estrogen deficiency. Herein, we aimed to investigate the mechanisms and consequences of this phenomenon by establishing a mouse model of osteoporosis caused by ovariectomy (OVX)-mimicked estrogen deficiency.MethodsMicro-CT, osmium tetroxide staining, and histological analyses were performed to examine the changes in bone microstructure, BMAT and white adipose tissue (WAT) in OVX mice compared to sham mice. The osteogenesis and adipogenesis of primary bone marrow stromal cells (BMSCs) isolated from sham and OVX mice were compared in vitro. The molecular phenotypes of BMAT and WAT were determined and compared by quantitative PCR (qPCR). Bone marrow adipocyte-conditioned medium (BMA CM) was prepared from sham or OVX mice for coculture assays, and BMSCs or bone marrow monocytes/macrophages (BMMs) were isolated and subjected to osteoblast and osteoclast differentiation, respectively. Cell staining and qPCR were used to assess the effects of BMAT on bone metabolism.ResultsOVX-induced estrogen deficiency induced reductions in both cortical and trabecular bone mass along with an expansion of BMAT volume. At the cellular level, loss of estrogen inhibited BMSC osteogenesis and promoted BMSC adipogenesis, whereas addition of estradiol exerted the opposite effects. In response to estrogen deficiency, despite the common proinflammatory molecular phenotype observed in both fat depots, BMAT, unlike WAT, unexpectedly exhibited an increase in adipocyte differentiation and lipolytic activity as well as the maintenance of insulin sensitivity. Importantly, BMAT, but not WAT, presented increased mRNA levels of both BMP receptor inhibitors (Grem1, Chrdl1) and Rankl following OVX. In addition, treatment with BMA CM, especially from OVX mice, suppressed the osteoblast differentiation of BMSCs while favoring the osteoclast differentiation of BMMs.ConclusionOur study illustrates that OVX-induced estrogen deficiency results in bone loss and BMAT expansion by triggering imbalance between the osteogenesis and adipogenesis of BMSCs. Furthermore, expanded BMAT, unlike typical WAT, may negatively regulate bone homeostasis through paracrine inhibition of osteoblast-mediated bone formation and promotion of osteoclast-mediated bone resorption.

Dose-Dependent Effect of Estrogen Suppresses the Osteo-Adipogenic Transdifferentiation of Osteoblasts Via Canonical Wnt Signaling Pathway

Effects of 17Β-Estradiol on Adiponectin Regulation of the Expression of Osteoprotegerin and Receptor Activator of Nuclear Factor-Κb Ligand

Dose-response estrogen promotes osteogenic differentiation via GPR40 (FFAR1) in murine BMMSCs

Effects of Total Flavonoids of Epimedium on Bone Marrow Adipose Tissue in Ovariectomized Rats

The unique role of bone marrow adipose tissue in ovariectomy-induced bone loss in mice

Proteomic Analysis of Estrogen-Mediated Signal Transduction in Osteoclasts Formation

Emodin enhances osteogenesis and inhibits adipogenesis

Estrogen receptor α36 mediates a bone-sparing effect of 17β-estrodiol in postmenopausal women.

Integrative analyses of genetic mechanisms responsible for bone–fat imbalance in osteoporosis

Steroid effects on osteogenesis through mesenchymal cell gene expression

Estrogen receptor-alpha36 mediates a bone-sparing effect of 17beta-estrodiol in postmenopausal women

Impact of estrogen on the Notch signaling pathway in human bone mesenchymal stem cells derived from patients with postmenopausal osteoporosis

Transdifferentiation Between Bone and Fat on Bone Metabolism.

DEPTOR exacerbates bone–fat imbalance in osteoporosis by transcriptionally modulating BMSC differentiation

[The effect of estrogen on adipogenic differentiation of rat bone mesenchymal stem cells].

Effects of 17 Β -Estradiol on the Expression of Interstitial Collagenases-8 and −13 (MMP-8 and MMP-13) and Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) in Ovariectomized Rat Osteoblastic Cells

Estrogen inhibits osteoclasts formation and bone resorption via microRNA‐27a targeting PPARγ and APC

Correlation of obesity and osteoporosis: Effect of free fatty acids on bone marrow-derived mesenchymal stem cell differentiation

Mesenchymal Progenitors in Osteopenias of Diverse Pathologies: Differential Characteristics in the Common Shift from Osteoblastogenesis to Adipogenesis

Expression Patterns of Transcription Factor PPARγ and C/EBP Family Members During in Vitro Adipogenesis of Human Bone Marrow Mesenchymal Stem Cells

Differentiation of human mesenchymal stem cells: the potential mechanism for estrogen-induced preferential osteoblast versus adipocyte differentiation.